FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Med (Praha) / Cannabidiol and the possibilities of its use in veterinary...
Veterinarni medicina2022; 67(9); 455-462; doi: 10.17221/127/2021-VETMED

Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: A brief review.

Abstract: In connection with the use of cannabinoids for therapeutic purposes in human medicine, there is increased attention for their use in veterinary medicine, particularly by the owners of companion animals and horses. Therefore, veterinarians are expected to face this interest and have the corresponding knowledge on these substances. Presently, it is not possible to use medical marijuana (in terms of the dried cannabis flowers) for veterinary purposes in many countries, but there is increasing evidence that isolated cannabinoids also have beneficial effects (namely cannabidiol - CBD). Thus, this review summarises the possible therapeutic implications of CBD within the scope of evidence-based medicine, particularly in dogs and horses in association with the treatment of pain, epilepsy and anxiety in order to provide veterinarians with a concise overview of scientific findings in this field.
Copyright: © 2022 Landa et al.
Get Full Text
Publication Date: 2022-06-17 PubMed ID: 38715968PubMed Central: PMC11071133DOI: 10.17221/127/2021-VETMEDGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the potential use of cannabinoids, specifically cannabidiol (CBD), for the treatment of several conditions in dogs and horses. The study aims to provide knowledge on the use of cannabinoids in veterinary medicine, targeting conditions like pain, epilepsy, and anxiety.

Introduction and Motivation

  • The motivation behind this research is the increasing interest in using cannabinoids for treating various health conditions in veterinary medicine. As medical marijuana receives widespread acceptance and acknowledgment for its therapeutic benefits in humans, there is growing curiosity about its potential veterinary applications.
  • The research also acknowledges that despite this interest, many jurisdictions do not currently permit the use of medical marijuana (namely, the dried flowers of cannabis) in veterinary practices. Consequently, the study aims to investigate the therapeutic implications of isolated cannabinoids, specifically cannabidiol (CBD).

Scope and Focus of the Research

  • In this research, the focus is on utilizing CBD in veterinary practices, with a particular emphasis on treating horses and dogs.
  • The disorders being targeted for treatment in these animals include pain, epilepsy, and anxiety, conditions often treated with CBD products in humans.
  • The study is not merely interested in understanding if CBD can be used in veterinary medicine but aims to explore this within the framework of evidence-based medicine. This approach means the research relies on the best available scientific evidence to make informed medical decisions.

Implications of the Research

  • The findings summarised in this review could provide veterinarians with a comprehensive overview of the scientific proof regarding the use of CBD in treating specific conditions in dogs and horses.
  • Such research has the potential to open up new treatment regimes in veterinary care, particularly concerning managing pain, epilepsy, and anxiety in dogs and horses. It might also influence legislative policies concerning the use of cannabinoids in veterinary medicine.
  • This study could also pave the way for further research into the potential uses of various cannabinoids in veterinary medicine, beyond just CBD.

Cite This Article

APA
Landa L, Trojan V, Demlova R, Jurica J, Hrib R. (2022). Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: A brief review. Vet Med (Praha), 67(9), 455-462. https://doi.org/10.17221/127/2021-VETMED

Publication

Veterinarni medicina
ISSN: 0375-8427
NlmUniqueID: 0063417
Country: Czech Republic
Language: English
Volume: 67
Issue: 9
Pages: 455-462

Researcher Affiliations

Landa, Leos
  • Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Clinical Pharmacology Unit, Centre for Translational Medicine, International Clinical Research Centre, St. Anne's University Hospital, Brno, Czech Republic.
Trojan, Vaclav
  • Clinical Pharmacology Unit, Centre for Translational Medicine, International Clinical Research Centre, St. Anne's University Hospital, Brno, Czech Republic.
Demlova, Regina
  • Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Jurica, Jan
  • Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Hrib, Radovan
  • Clinical Pharmacology Unit, Centre for Translational Medicine, International Clinical Research Centre, St. Anne's University Hospital, Brno, Czech Republic.
  • Centre for Pain Management, Department of Anesthesiology and Intensive Care, St. Anne's University Hospital, Brno, Czech Republic.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 47 references
  1. Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants (Basel) 2019 Dec 25;9(1):21.
    pmc: PMC7023045pubmed: 31881765
  2. Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res 2018 Jul;82(3):178-83.
    pmc: PMC6038832pubmed: 30026641
  3. Brioschi FA, Di Cesare F, Gioeni D, Rabbogliatti V, Ferrari F, D’Urso ES, Amari M, Ravasio G. Oral transmucosal cannabidiol oil formulation as part of a multimodal analgesic regimen: Effects on pain relief and quality of life improvement in dogs affected by spontaneous osteoarthritis. Animals (Basel) 2020 Aug 26;10(9):1505.
    pmc: PMC7552307pubmed: 32858828
  4. Chiocchetti R, Rinnovati R, Tagliavia C, Stanzani A, Galiazzo G, Giancola F, De Silva M, Capodanno Y, Spadari A. Localisation of cannabinoid and cannabinoid-related receptors in the equine dorsal root ganglia. Equine Vet J 2021 May;53(3):549-57.
    pubmed: 32524649
  5. Collins A, Porr S, Davis A. Pharmacokinetics of a single feeding of pelleted cannabidiol in horses. ORCA Travel & Research Grants [Internet] 2019 Aug 1.
  6. Daris B, Tancer Verboten M, Knez Z, Ferk P. Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn J Basic Med Sci 2019 Feb 12;19(1):14-23.
    pmc: PMC6387667pubmed: 30172249
  7. Davis H. Novel analgesics and the impact of route of administration in the horse [PhD thesis]. Alabama: Auburn University; 2019.
  8. De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain 2019;160(1):136-50.
    pmc: PMC6319597pubmed: 30157131
  9. de Mello Schier AR, de Oliveira Ribeiro NP, Coutinho DS, Machado S, Arias-Carrion O, Crippa JA, Zuardi AW, Nardi AE, Silva AC. Antidepressant-like and anxiolytic-like effects of cannabidiol: A chemical compound of Cannabis sativa. CNS Neurol Disord Drug Targets 2014;13(6):953-60.
    pubmed: 24923339
  10. Deabold KA, Schwark WS, Wolf L, Wakshlag JJ. Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals (Basel) 2019 Oct 19;9(10):832.
    pmc: PMC6826847pubmed: 31635105
  11. Denapoli A, Denapoli C. Method of reducing stress and anxiety in equines. United States Patent 2020 Apr; Patent No.: US 10,624,936 B2.
  12. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017 May 25;376(21):2011-20.
    pubmed: 28538134
  13. Draeger AL, Hoffman LK, Godwin PR, Davis AJ, Porr SA. Pharmacokinetics of a single feeding of pelleted cannabidiol in horses. Steeplechase: An ORCA Student Journal 2020;4(2): [12].
  14. Ellis KL, Contino EK. Treatment using cannabidiol in a horse with mechanical allodynia. Equine Vet Educ 2021;33(4):e79-e82.
  15. Freundt-Revilla J, Kegler K, Baumgartner W, Tipold A. Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system. PLoS One 2017 Jul 10;12(7):e0181064.
    pmc: PMC5507289pubmed: 28700706
  16. Gamble LJ, Boesch JM, Frye CW, Schwark WS, Mann S, Wolfe L, Brown H, Berthelsen ES, Wakshlag JJ. Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs. Front Vet Sci 2018;23(5):165.
    pmc: PMC6065210pubmed: 30083539
  17. Gaston TE, Friedman D. Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy Behav 2017 May;70(Pt B):313-8.
    pubmed: 28087250
  18. Ghovanloo MR, Shuart NG, Mezeyova J, Dean RA, Ruben PC, Goodchild SJ. Inhibitory effects of cannabidiol on voltage-dependent sodium currents. J Biol Chem 2018 Oct 26;293(43):16546-58.
    pmc: PMC6204917pubmed: 30219789
  19. Gusho CA, Court T. Cannabidiol: A brief review of its therapeutic and pharmacologic efficacy in the ma-nagement of joint disease. Cureus 2020 Mar 23;12(3):e7375.
    pmc: PMC7176325pubmed: 32328386
  20. Jiang R, Yamaori S, Takeda S, Yamamoto I, Watanabe K. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes. Life Sci 2011 Aug 1;89(5-6):165-70.
    pubmed: 21704641
  21. Jones K, Thomas E, Draeger A, Porr S. Evaluation of CBD supplementation in the horse [Internet]. 2018.
  22. Kogan L, Schoenfeld-Tacher R, Hellyer P, Rishniw M. US veterinarians’ knowledge, experience, and perception regarding the use of cannabidiol for canine medical conditions. Front Vet Sci 2019a Jan 10;5:338.
    pmc: PMC6338022pubmed: 30687726
  23. Kogan L, Hellyer P, Schoenfeld-Tacher R. Dog owners’ use and perceptions of cannabis products. Can Vet J 2019b Jul;60(7):749-55.
    pmc: PMC6563876pubmed: 31281193
  24. Kogan L, Hellyer P, Downing R. The use of cannabidiol-rich hemp oil extract to treat canine osteoarthritis-related pain: A pilot study. AHVMA J 2020;58:35-45.
  25. Krause A. CBD case studies: Anxiety and epilepsy [Internet]. Innovative Veterinary Care Journal 2019.
  26. Landa L, Sulcova A, Gbelec P. The use of cannabinoids in animals and therapeutic implications for veterinary medicine: A review. Vet Med-Czech 2016;61(3):111-22.
  27. Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol 2015 Oct;172(20):4790-805.
    pmc: PMC4621983pubmed: 26218440
  28. Lehmann C, Fisher NB, Tugwell B, Szczesniak A, Kelly M, Zhou J. Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes. Clin Hemorheol Microcirc 2016;64(4):655-62.
    pubmed: 27767974
  29. Maa E, Figi P. The case for medical marijuana in epilepsy. Epilepsia 2014 Jun;55(6):783-6.
    pubmed: 24854149
  30. Masataka N. Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders. Front Psychol 2019 Nov 8;10:2466.
    pmc: PMC6856203pubmed: 31787910
  31. McGrath S, Bartner LR, Rao S, Kogan LR, Hellyer PW. A report of adverse effects associated with the administration of cannabidiol in healthy dogs. J Amer Holistic Vet Med Assoc 2018;52:34-8.
  32. McGrath S, Bartner LR, Rao S, Packer RA, Gustafson DL. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. J Am Vet Med Assoc 2019 Jun 1;254(11):1301-8.
    pubmed: 31067185
  33. Mechoulam R, Shvo Y. The structure of cannabidiol. Tetrahedron 1963 Dec;19(12):2073-8.
    pubmed: 5879214
  34. Mejia S, Duerr FM, Griffenhagen G, McGrath S. Evaluation of the effect of cannabidiol on naturally occurring osteoarthritis-associated pain: A pilot study in dogs. J Am Anim Hosp Assoc 2021 Mar 1;57(2):81-90.
    pubmed: 33450016
  35. Mercer MA, Davis JL. Cannabinoids in veterinary medicine: Is there evidence to support the trend?. Equine Vet Educ 2021;33(4):177-9.
  36. Mlost J, Bryk M, Starowicz K. Cannabidiol for pain treatment: Focus on pharmacology and mechanism of action. Int J Mol Sci 2020 Nov 23;21(22):8870.
    pmc: PMC7700528pubmed: 33238607
  37. Morales P, Hurst DP, Reggio PH. Molecular targets of the phytocannabinoids: A complex picture. Prog Chem Org Nat Prod 2017;103:103-31.
    pmc: PMC5345356pubmed: 28120232
  38. Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE. Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom 1986 Feb;13(2):77-83.
    pubmed: 2937482
  39. Peng J, Fan M, An C, Ni F, Huang W, Luo J. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharmacol Toxicol 2022 Apr;130(4):439-56.
    pubmed: 35083862
  40. Preedy VR. Handbook of cannabis and related pathologies: Biology, pharmacology, diagnosis, and treatment. Amsterdam: Academic Press; 2017. 1143 p..
  41. Rodriguez-Munoz M, Onetti Y, Cortes-Montero E, Garzon J, Sanchez-Blazquez P. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor. Mol Brain 2018 Sep 17;11(1):51.
    pmc: PMC6142691pubmed: 30223868
  42. Samara E, Bialer M, Mechoulam R. Pharmacokinetics of cannabidiol in dogs. Drug Metab Dispos 1988 May-Jun;16(3):469-72.
    pubmed: 2900742
  43. Seltzer ES, Watters AK, MacKenzie D Jr, Granat LM, Zhang D. Cannabidiol (CBD) as a promising anti-cancer drug. Cancers (Basel) 2020 Oct 30;12(11):3203.
    pmc: PMC7693730pubmed: 33143283
  44. Simpson AC, Bradley CV, Schissler JR. Probable cutaneous adverse drug reaction due to a cannabidiol-containing hemp oil product in a dog. Vet Dermatol 2020 Oct;31(5):404-e108.
    pubmed: 32735064
  45. Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: A systematic review. Drug Metab Rev 2014 Feb;46(1):86-95.
    pubmed: 24160757
  46. Verrico CD, Wesson S, Konduri V, Hofferek CJ, Vazquez-Perez J, Blair E, Dunner K Jr, Salimpour P, Decker WK, Halpert MM. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. Pain 2020 Sep 1;161(9):2191-202.
    pmc: PMC7584779pubmed: 32345916
  47. Wessmann A, Stalin K, Kisielewicz C. Use of cannabidiol (CBD) in dogs and cats [Internet]. BSAVA Library 2021.
Subscribe to our newsletter
Join 99,101 horse owners like you who receive our email updates on horse health and nutrition.